Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76Lymphoma 73Lymphoma, Non-Hodgkin 66Hodgkin Disease 53Leukemia 40Lymphoma, Large B-Cell, Diffuse 37Multiple Myeloma 35Myelodysplastic Syndromes 34Lymphoma, Mantle-Cell 33Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Burkitt Lymphoma 30Lymphoma, Follicular 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Large-Cell, Immunoblastic 15Recurrence 12Myeloproliferative Disorders 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 9Hematologic Neoplasms 9Dendritic Cell Sarcoma, Interdigitating 9Lymphoma, T-Cell 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Biphenotypic, Acute 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Neoplasms 6

Interventions

ofatumumab 1liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Surveys and Questionnaires 1Sirolimus 1Rituximab 1Ritonavir 1Quality of Life 1Prednisone 1Metformin 1Lenalidomide 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphadenopathy × Granulocyte Colony-Stimulating Factor × Lymphoid × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡